New number of shares and votes in Biovitrum AB (publ)
(Thomson Reuters ONE) - The total number of shares in Biovitrum AB (publ) as per 30 September2009 amounts to in total 50,911,901 shares, whereof 50,396,316 commonshares and 515,585 class C shares, corresponding to in total50,447,874.5 votes. The increase in the number of shares and votesresults from an issue of 231,585 class C shares under Biovitrum'slong term performance based share program. The class C shares areintended to secure delivery of shares under the program.For more information please contact:BiovitrumGöran Arvidson, CFOPhone: +46 8 697 23 68Erik Kinnman, VP Investor RelationsPhone: +46 8 697 21 50erik.kinnman(at)biovitrum.comAbout BiovitrumBiovitrum is an international pharmaceutical company that marketsspecialist pharmaceuticals in several regions. Using its expertiseand experience Biovitrum takes scientific innovation to patients withsignificant unmet medical need. Research expertise and capabilitiesare focused on development and production of biotechnologytherapeutics within our prioritized areas of hemophilia,inflammation/autoimmune diseases, cancer supportive care andmalabsorption. The company has revenues of approximately SEK 1.2billion and around 400 employees. The company head office is locatedin Sweden and it is listed on the Stockholm OMX Nordic Exchange. Formore information please visit www.biovitrum.comBiovitrum AB (publ) may be required to disclose the informationprovided herein pursuant to the Swedish Securities Markets Act. Theinformation was provided for public release on September 30, 2009 at11:30 a.m. CET.http://hugin.info/134557/R/1344868/322625.pdfThis announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.
Datum: 30.09.2009 - 11:30 Uhr
Sprache: Deutsch
News-ID 6419
Anzahl Zeichen: 0
contact information:
Town:
London
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 222 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"New number of shares and votes in Biovitrum AB (publ)"
steht unter der journalistisch-redaktionellen Verantwortung von
Biovitrum (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
